Because exogenous administration of CMKLR1 ligands decreases the severity of antigen‐induced lung inflammation and AHR, we hypothesized that CMKLR1 limits the severity of lung pathophysiology induced by the non‐atopic asthma stimulus, O3. This evidence concerns the gene CMKLR1 and asthma.